1. Home
  2. ARTL vs UK Comparison

ARTL vs UK Comparison

Compare ARTL & UK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$1.45

Market Cap

1.4M

Sector

Health Care

ML Signal

N/A

Logo Ucommune International Ltd

UK

Ucommune International Ltd

N/A

Current Price

$1.20

Market Cap

1.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTL
UK
Founded
2011
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.3M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
ARTL
UK
Price
$1.45
$1.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 27.2K
10.3K
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.24
52 Week High
$179.19
$5.90

Technical Indicators

Market Signals
Indicator
ARTL
UK
Relative Strength Index (RSI) 26.43 23.60
Support Level $0.52 $0.41
Resistance Level $6.81 $2.22
Average True Range (ATR) 0.25 0.14
MACD 0.00 -0.04
Stochastic Oscillator 0.00 6.38

Price Performance

Historical Comparison
ARTL
UK

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has two operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.

Share on Social Networks: